Cooper Companies Inc (NYSE:COO) Given Consensus Rating of “Buy” by Analysts

Shares of Cooper Companies Inc (NYSE:COO) have received a consensus rating of “Buy” from the thirteen ratings firms that are presently covering the stock, Marketbeat reports. One analyst has rated the stock with a sell recommendation, one has issued a hold recommendation and eleven have assigned a buy recommendation to the company. The average twelve-month price objective among analysts that have updated their coverage on the stock in the last year is $315.36.

Several research firms have weighed in on COO. Zacks Investment Research upgraded shares of Cooper Companies from a “hold” rating to a “buy” rating and set a $336.00 price target on the stock in a research report on Friday, June 7th. Wells Fargo & Co increased their price target on shares of Cooper Companies from $325.00 to $356.00 and gave the stock an “outperform” rating in a research report on Monday, June 10th. Northcoast Research reiterated a “buy” rating and issued a $340.00 price target (up from $331.00) on shares of Cooper Companies in a research report on Monday, June 3rd. Raymond James increased their price target on shares of Cooper Companies from $300.00 to $325.00 and gave the stock an “outperform” rating in a research report on Wednesday, March 6th. Finally, BMO Capital Markets increased their price target on shares of Cooper Companies from $306.00 to $320.00 and gave the stock an “outperform” rating in a research report on Wednesday, March 6th.

Cooper Companies stock traded up $1.14 during midday trading on Tuesday, reaching $330.08. 9,195 shares of the company traded hands, compared to its average volume of 318,402. The stock has a market cap of $16.28 billion, a price-to-earnings ratio of 28.72, a price-to-earnings-growth ratio of 2.50 and a beta of 0.78. The company’s 50 day simple moving average is $305.23. Cooper Companies has a 12 month low of $228.65 and a 12 month high of $334.33. The company has a debt-to-equity ratio of 0.42, a current ratio of 1.21 and a quick ratio of 0.68.

Cooper Companies (NYSE:COO) last issued its quarterly earnings data on Thursday, May 30th. The medical device company reported $2.94 earnings per share for the quarter, beating the Zacks’ consensus estimate of $2.76 by $0.18. The company had revenue of $654.30 million for the quarter, compared to the consensus estimate of $655.00 million. Cooper Companies had a net margin of 16.46% and a return on equity of 17.25%. The firm’s revenue for the quarter was up 3.6% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $2.86 earnings per share. Sell-side analysts forecast that Cooper Companies will post 12.24 earnings per share for the current fiscal year.

In other news, Director Gary S. Petersmeyer sold 355 shares of the firm’s stock in a transaction on Monday, June 17th. The shares were sold at an average price of $323.92, for a total transaction of $114,991.60. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Jody S. Lindell sold 2,943 shares of the firm’s stock in a transaction on Monday, April 1st. The shares were sold at an average price of $296.28, for a total transaction of $871,952.04. The disclosure for this sale can be found here. Insiders have sold a total of 85,347 shares of company stock worth $27,259,130 over the last 90 days. Insiders own 1.70% of the company’s stock.

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Nordea Investment Management AB grew its stake in Cooper Companies by 1.4% during the first quarter. Nordea Investment Management AB now owns 2,598 shares of the medical device company’s stock valued at $769,000 after acquiring an additional 36 shares in the last quarter. Dupont Capital Management Corp grew its stake in Cooper Companies by 4.4% during the fourth quarter. Dupont Capital Management Corp now owns 881 shares of the medical device company’s stock valued at $224,000 after acquiring an additional 37 shares in the last quarter. Thrivent Financial for Lutherans grew its stake in Cooper Companies by 1.8% during the fourth quarter. Thrivent Financial for Lutherans now owns 2,141 shares of the medical device company’s stock valued at $545,000 after acquiring an additional 37 shares in the last quarter. Archford Capital Strategies LLC grew its stake in Cooper Companies by 4.7% during the first quarter. Archford Capital Strategies LLC now owns 942 shares of the medical device company’s stock valued at $279,000 after acquiring an additional 42 shares in the last quarter. Finally, Rehmann Capital Advisory Group grew its stake in Cooper Companies by 24.3% during the fourth quarter. Rehmann Capital Advisory Group now owns 220 shares of the medical device company’s stock valued at $56,000 after acquiring an additional 43 shares in the last quarter. 95.95% of the stock is owned by institutional investors.

About Cooper Companies

The Cooper Companies, Inc operates as a medical device company worldwide. It operates through CooperVision and CooperSurgical business units. The company develops, manufactures, and markets a range of contact lenses, including spherical lenses, and toric and multifocal lenses that correct near- and farsightedness, as well as addresses various complex visual defects, such as astigmatism and presbyopia.

Recommended Story: Total Return

Analyst Recommendations for Cooper Companies (NYSE:COO)

Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.